Ankylosing Spondylitis Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - Pfizer, Merck, Abbvie, Kyowa Kirin, UCB Biopharma, Galapagos NV, Sun Pharmaceuticals, and many others.

DelveInsight's "Ankylosing Spondylitis Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Ankylosing Spondylitis Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Ankylosing Spondylitis market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Ankylosing Spondylitis: An Overview
Ankylosing spondylitis (AS) is a chronic immune-mediated inflammatory arthritis included in the group of spondyloarthritis (SpA). It is also called Bechterew's disease, a form of arthritis that primarily affects the spine, although other joints may also be involved. The disease causes inflammation of the spinal joints (vertebrae) that can lead to severe, chronic pain and discomfort.

Ankylosing spondylitis has no known specific cause, though genetic factors seem to be involved. In particular, people who have the HLA-B27 gene are at increased risk of developing ankylosing spondylitis. However, the HLA-B27 allele accounts for only 20% of the genetic effect. Besides, other alleles, especially HLA-B, are thought to play an essential role in the disease.

Ankylosing Spondylitis Market Key Facts
As per DelveInsight's estimates, there were 1,389,100+ prevalent cases of AS in 2017 in the 7MM.
The United States accounted for the highest prevalent population of Ankylosing Spondylitis, followed by EU5 and Japan.
AS is typically diagnosed in people younger than 40 years, and about 80% of patients develop first symptoms when they were younger than 30 years. Less than 5% of patients present when they are older than 45 years (Wenker et al., 2019).

Find a sample copy of the Ankylosing Spondylitis Market report at:
https://www.delveinsight.com/sample-request/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ankylosing Spondylitis Market
Ankylosing Spondylitis market size is expected to change during the forecast period owing to the launch of upcoming therapies and biosimilars.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Ankylosing Spondylitis market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Ankylosing Spondylitis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request a sample and discover more about the report offerings @
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ankylosing Spondylitis Epidemiology
The epidemiology section covers detailed insights into the historical and current Ankylosing Spondylitis patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Explore more about the Ankylosing Spondylitis Epidemiology @
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ankylosing Spondylitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Ankylosing Spondylitis market or expected to get launched in the market during the study period. The analysis covers Ankylosing Spondylitis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Ankylosing Spondylitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for a sample report to understand more about the Ankylosing Spondylitis pipeline development activities @
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Ankylosing Spondylitis Therapeutics Assessment
Currently, the cure for Ankylosing Spondylitis is not available in the market, and the available therapies mainly help to reduce the discomfort, pain, and inflammation caused by Ankylosing Spondylitis. In terms of molecule type, the market can be segregated into small molecules, biologics, and biosimilars.

Some of the key companies in the Ankylosing Spondylitis Market include:
Pfizer
Merck
Abbvie
Kyowa Kirin
UCB Biopharma
Galapagos NV
Sun Pharmaceuticals
And many others.

Ankylosing Spondylitis Therapies covered in the report include:
Tofacitinib
Bimekizumab
Filgotinib
Tildrakizumab
Upadacitinib
KHK4827
And many more.

Learn more about the emerging therapies & key companies in the Ankylosing Spondylitis Therapeutics Market @
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Ankylosing Spondylitis Competitive Intelligence Analysis
4. Ankylosing Spondylitis Market Overview at a Glance
5. Ankylosing Spondylitis Disease Background and Overview
6. Ankylosing Spondylitis Patient Journey
7. Ankylosing Spondylitis Epidemiology and Patient Population
8. Ankylosing Spondylitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Ankylosing Spondylitis Unmet Needs
10. Key Endpoints of Ankylosing Spondylitis Treatment
11. Ankylosing Spondylitis Marketed Products
12. Ankylosing Spondylitis Emerging Therapies
13. Ankylosing Spondylitis Seven Major Market Analysis
14. Attribute Analysis
15. Ankylosing Spondylitis Market Outlook (7 major markets)
16. Ankylosing Spondylitis Access and Reimbursement Overview
17. KOL Views on the Ankylosing Spondylitis Market.
18. Ankylosing Spondylitis Market Drivers
19. Ankylosing Spondylitis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Ankylosing Spondylitis Market report here:
https://www.delveinsight.com/sample-request/ankylosing-spondylitis-as-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.